I had my ICU nurse missus take a look over CC a while back and she even said it could be used to grow organs.
Not saying it will but it could going off her knowledge and she has an IQ of 141. I've always said CC is the kingpin yet most overlook it. Clinical evidence is proven 100%, regulatory approvals are done, income has started. It's milestones ahead and something any company would give their right arm for.
Looks like the company is and always has been well ahead in knowledge and experience to get the product known and sold worldwide in comparison to the stupid downrampers such as meerkat and Im QE ramblings.
WE never heard any of them say AHZ should be at EACTS lol
Ann: Admedus to showcase CardioCel at EACTS Annual Meeting, page-75
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |